Companies: 10,795·Total market cap: $144.5T
Legend Biotech Corporation

Legend Biotech Corporation

LEGNNASDAQHealthcare● Active
$31.80
$-0.82(-2.51%)
Market Cap$5.9B
P/E Ratio—
52W High$45.297
52W Low$16.24
SEC Filings

Legend Biotech Corporation (LEGN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001801198 · LEGN · NASDAQ · as of Jun 8, 2026

Filing snapshot

346
Total Filings
6-K
Latest Form
2026-06-02
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001801198 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-10
Fiscal Year End
Mar 10, 2026
Accession No.
0001801198-26-000008
Primary Document
legn-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001801198 · Accession 0001801198-26-000008

Latest Key Filings

10-QQuarterly Report

No recent filings

8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-21
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-14
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 278 filingsForm 4 / 144 hidden· 346 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001801198  |  Exchange: NASDAQ · Healthcare

Legend Biotech Corporation (NASDAQ: LEGN) has submitted 346 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001801198, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Legend Biotech Corporation's most comprehensive regulatory disclosure. The most recent Legend Biotech Corporation 10-K was filed on 2026-03-10 for fiscal year ending 2026. Historical LEGN 10-K annual reports are available from 2020 through 2026.

Investors researching Legend Biotech Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
SRRK SEC Filings →CGON SEC Filings →CELC SEC Filings →XENE SEC Filings →ADPT SEC Filings →IDYA SEC Filings →TARS SEC Filings →IRON SEC Filings →
→ LEGN Financials→ LEGN Earnings→ LEGN Insider Trades

Frequently Asked Questions

LEGN SEC Filings · 8 questions

Legend Biotech Corporation (LEGN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 346 filings and access original documents at no cost. Legend Biotech Corporation's CIK is 0001801198.

LEGN SEC filingsLegend Biotech Corporation SEC documentsfind LEGN 10-K